Researchers found that COVID-19 may accelerate biological processes linked to Alzheimer’s, showing changes in brain-related ...

In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Neuroscience is undergoing a profound transformation aided by developments in artificial intelligence (AI), particularly in how brain imaging techniques are ...